Malignant Melanoma: Prognostic Factors
作者： Terence J. Harrist , Calvin L. Day
DOI: 10.1007/978-1-4613-2043-2_5
关键词: Prognostic model 、 Internal medicine 、 Melanoma 、 Oncology 、 Regional lymph node metastasis 、 Incidence (epidemiology)
摘要: Understanding prognosis of malignant melanoma is becoming increasingly important. Firstly, the incidence cutaneous rising rapidly [1]. There has been an 80% increase in United States between 1973 and 1980 [2]. Up to one every 200 citizens may expect develop a during next generation. Secondly, understanding interplay importance individual prognostic factors allow insight into biology tumor. Thirdly, allows general outline therapy for subsets patients with explicit tailoring patients. Lastly, although not least importance, ability give patient some gravity expected outcome his particular case. This last factor extreme because many physicians equate diagnosis grim outlook as cited older literature.
springer.com
sci-hub.st 参考文章(34)
The natural break points for primary-tumor thickness in clinical Stage I melanoma. The New England Journal of Medicine. ,vol. 305, pp. 1155- 1155 ,(1981) , 10.1056/NEJM198111053051916
U. Veronesi, J. Adamus, D.C. Bandiera, I.O. Brennhovd, E. Caceres, N. Cascinelli, F. Claudio, R.L. Ikonopisov, V.V. Javorskj, S. Kirov, A. Kulakowski, J. Lacour, F. Lejeune, Z. Mechl, A. Morabito, I. Rode, S. Sergeev, E. van Slooten, K. Szczygiel, N.N. Trapeznikov, R.I. Wagner, Stage I melanoma of the limbs. Immediate versus delayed node dissection. Tumori. ,vol. 66, pp. 373- 396 ,(1980) , 10.1177/030089168006600311
Charles M Balch, W. A. Maddox, A. L. Ingalls, T. M. Murad, S. J. Soong, A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery. ,vol. 86, pp. 343- 351 ,(1979)
Gumport Sl, Sober Aj, Malt Ra, Postel A, Golomb Fm, Cosimi Ab, Roses Df, Harris Mn, Mihm Mc, Kopf Aw, Day Cl, Fitzpatrick Tb, Hennessey P, Raker Jw, Lew Ra, Gorstein F, Wood Wc, A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease. Surgery. ,vol. 89, pp. 599- 603 ,(1981)
E V Sugarbaker, C M McBride, Melanoma of the trunk: the results of surgical excision and anatomic guidelines for predicting nodal metastasis. Surgery. ,vol. 80, pp. 22- 30 ,(1976)
GEORGE E. BLOCK, SHATTUCK W. HARTWELL, Malignant Melanoma: A Study of 217 Cases Part Ii Annals of Surgery. ,vol. 154, pp. 74- 87 ,(1961) , 10.1097/00000658-196112000-00010
Calvin L. Day, Arthur J. Sober, Alfred W. Kopf, Robert A. Lew, Martin C. Mihm, Frederick M. Golomb, Allen Postel, Patrick Hennessey, Matthew N. Harris, Stephen L. Gumport, John W. Raker, Ronald A. Malt, A.Benedict Cosimi, William C. Wood, Daniel F. Roses, Fred Gorstein, Thomas B. Fitzpatrick, A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease. American Journal of Surgery. ,vol. 142, pp. 247- 251 ,(1981) , 10.1016/0002-9610(81)90286-5
A K Bhan, A J Sober, M C Mihm, T J Harrist, D J Ruiter, Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma. Journal of Immunology. ,vol. 129, pp. 2808- 2815 ,(1982)
Mark H. Greene, Wallace H. Clark, Margaret A. Tucker, David E. Elder, Kenneth H. Kraemer, DuPont Guerry, William K. Witmer, Jean Thompson, Isabel Matozzo, Mary C. Fraser, Acquired Precursors of Cutaneous Malignant Melanoma New England Journal of Medicine. ,vol. 312, pp. 91- 97 ,(1985) , 10.1056/NEJM198501103120205
C. L. Day, M. C. Mihm, R. A. Lew, A. W. Kopf, A. J. Sober, T. B. Fitzpatrick, Cutaneous malignant melanoma: Prognostic guidelines for physicians and patients CA: A Cancer Journal for Clinicians. ,vol. 32, pp. 113- 122 ,(1982) , 10.3322/CANJCLIN.32.2.113